Special Issue "Neonatal Clinical Pharmacology"
Deadline for manuscript submissions: 1 April 2024 | Viewed by 5831
Interests: perinatal pharmacology; neonatal clinical pharmacology; PBPK in special populations; newborn; infant; lactation
Special Issues, Collections and Topics in MDPI journals
Special Issue in International Journal of Environmental Research and Public Health: Pharmacotherapy during Pregnancy, Childbirth and Lactation
Special Issue in Antibiotics: Therapeutic Drug Monitoring of Antimicrobials
Special Issue in Antibiotics: Therapeutic Drug Monitoring of Antimicrobials - 2nd Volume
Special Issue in International Journal of Environmental Research and Public Health: Second Edition: Pharmacotherapy during Pregnancy, Childbirth and Lactation
Special Issue in Pharmaceutics: Physiologically-Based Pharmacokinetic Modeling in Pregnancy, Lactation, and in Neonates: Achievements, Challenges and Future Directions
Special Issue in Children: 10th Anniversary of Children: Feature Papers in Neonatology
Interests: health sciences; pharmacology and therapeutics
Interests: neonatology; obstetrics; perinatal pharmacology; pharmacokinetics; pharmacodynamics; personalized ICT applications
Interests: pharmacology; pain and stress; placental pharmacology; sepsis treatment; neonatal apnea; neonatology neonatal pharmacology; perinatal pharmacology
Pharmacotherapy is a very powerful intervention to improve outcome, and this is also true in neonates. The prescription of a given drug should result in a safe and effective intervention to treat or prevent a specific disease or risk in an individual patient or population while avoiding disproportional side-effects. Clinical pharmacology supports these aims in predicting drug-related (side)-effects driven by pharmacokinetics (PK) and pharmacodynamics (PD). The dynamic changes related to maturation and growth in newborns result in a unique setting with extensive variability. Non-maturational changes (such as disease characteristics, drug–drug interactions, pharmacogenetics, and lactation-related exposure) further add to this variability.
This is a growing and active field of clinical research, with several reports on PK, PD, pharmacovigilance and -safety, and pharmaco-epidemiology having been published. This clinical field is further supported by novelties in the methods that are currently available (low-volume sample analysis, population PK analysis, physiology-based PK).
Prof. Dr. Karel Allegaert
Dr. Nadir Yalcin
Dr. Robert B. Flint
Dr. Sinno H.P. Simons
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Children is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- clinical pharmacology
- clinical pharmacy
- drug safety